Interferon alpha and ribavirin collaboratively regulate p38 mitogen-activated protein kinase signaling in hepatoma

Sheng-Fei He1, Wen Wang, Hao Ren

  • 1Department of Microbiology, Shanghai Key Laboratory of Medical Biodefense, Second Military Medical University, Shanghai 200433, China.

Cytokine
|February 16, 2013
PubMed

Insights

Interferon alpha (IFN-α) and ribavirin regulate p38 MAPK signaling, impacting hepatitis C virus (HCV) infection. Modulating this pathway may enhance antiviral therapies against HCV.

Area of Science:

  • Virology
  • Cellular Signaling
  • Hepatitis C Virus (HCV) Pathogenesis

Background:

  • The p38 mitogen-activated protein kinase (MAPK) pathway is implicated in HCV pathogenesis.
  • Interferon alpha (IFN-α) and ribavirin are key antiviral agents for HCV infection.
  • Understanding their effects on cellular signaling is crucial for optimizing HCV treatment.

Purpose of the Study:

  • To investigate the impact of IFN-α and ribavirin on p38 MAPK signaling in human hepatoma cells.
  • To elucidate the role of p38 MAPK in HCV replication and its modulation by antiviral treatments.

Main Methods:

  • Human hepatoma cells were treated with IFN-α and ribavirin, individually and in combination.
  • p38 MAPK phosphorylation levels were assessed using Western blotting.
  • siRNA-mediated knockdown of p38 MAPK was employed to study its functional role.
  • HCV RNA replication was quantified following p38 MAPK knockdown.

Main Results:

  • IFN-α induced p38 MAPK phosphorylation via Type I IFN receptor 2 (IFNAR2).
  • Ribavirin enhanced p38 MAPK phosphorylation.
  • Combined IFN-α and ribavirin treatment showed time-dependent effects on p38 MAPK phosphorylation.
  • HCV infection increased p38 MAPK phosphorylation, which was inhibited by IFN-α or ribavirin.
  • Knockdown of p38 MAPK enhanced ribavirin-dependent HCV RNA replication.

Conclusions:

  • IFN-α and ribavirin modulate p38 MAPK signaling pathways.
  • The regulation of p38 MAPK signaling by these antivirals may contribute to their anti-HCV effects.
  • Targeting p38 MAPK could be a potential strategy in HCV therapy.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...